Search Results for:
-
CEL-SCI COMPLETES PRIVATE PLACEMENT
The Alexandria, Va., company last week released findings with its BC-IL lymphokine cocktail in two patients who are enrolled in the company's Phase II clinical trialBioWorld Today | Monday, October 7, 1991 -
TRIALS BEGIN ON VIMRX AIDS DRUG
of Stamford, Conn., (NASDAQ:VMRX) said Thursday that the National Institute of Allergy and Infectious Diseases is beginning Phase I clinical trials of VimRxyn hypericin in its AIDS clinical trial unit at New York University Medical CenterBioWorld Today | Friday, October 4, 1991 -
ANTISENSE VS. INFLAMMATION
Isis is looking for ways to get the antisense strategy into clinical trials quickly, and is also investigating the cell adhesion molecule ELAM "and other inflammatory targets," Crooke saidBioWorld Today | Thursday, October 3, 1991 -
MID-ATLANTIC VENTURE FAIR HIGHLIGHTS
The system is currently being used in clinical trials of tumor infiltrating lymphocyte therapy in three U.S...It is seeking $15 million to fund further research and development and clinical trialsBioWorld Today | Thursday, October 3, 1991 -
BIOTECH STOCKS REBOUND FOR QUARTER
He told BioWorld that prices of third-tier stocks -- those companies with products one to three years away from clinical trials -- could tumble as much as 50 percent, with first and second-tier stocks making smaller, but still significant, correctionsBioWorld Today | Wednesday, October 2, 1991 -
GENENTECH SIGNS $20M PACT WITH XENOVA
The companies will jointly develop drug leads and conduct clinical trialsBioWorld Today | Tuesday, October 1, 1991 -
ESCAGENETICS GETS GRANT TO STUDY TAXOL
Taxol, which is derived from the bark and needles of the Pacific yew tree, has been shown in clinical trials to be effective in treating women with advanced breast and ovarian cancer...has been harvesting trees to provide the NCI with taxol for clinical trialsBioWorld Today | Tuesday, October 1, 1991 -
NEUROGEN STOCK UP 73%
Neurogen hopes in 1992 to begin clinical trials of its lead compound, NGD91-1, to treat anxietyBioWorld Today | Monday, September 30, 1991 -
HEMACARE EXTENDS WARRANT EXPIRATION
The company provides hemapheresis-derived products and services and is conducting clinical trials of its passive hyperimmune therapy to treat AIDS/ARC. (c) 1997 American Health ConsultantsBioWorld Today | Friday, September 27, 1991 -
EPITOPE GETS GRANT FOR HIV TEST
has been awarded a $467,000 grant to fund clinical trials for OraQuick, a 10-minute test for the detection of HIV antibodies in oral samplesBioWorld Today | Friday, September 27, 1991 -
PROCYTE TESTS AGAINST BOWEL DISEASE
The compound to be tested is an enema formulation with a different concentration of Iamin than the formulation now in clinical trials for diabetic ulcersBioWorld Today | Thursday, September 26, 1991 -
SYNERGEN CEO SAYS ANTRIL WILL COMPETE
While Synergen won't discuss the results of its Phase II clinical trials until some time before Thanksgiving, Saxe said that the 3 percent mortality improvement for patients receiving Centocor Corp.'s Centoxin in trials "was not a result I think we will have trouble with...In his presentation, Saxe updated clinical trial progressBioWorld Today | Wednesday, September 25, 1991 -
MONTGOMERY SECURITIES CONFERENCE
Genetic Therapy Inc.: The company will soon begin clinical trials inserting lymphocytes into tumor cells in vitroBioWorld Today | Wednesday, September 25, 1991 -
CELLPRO GROSSES $33 MILLION IN IPO
CellPro's Ceprate SC Stem Cell Concentrator is in clinical trials for use in bone marrow transplant patientsBioWorld Today | Wednesday, September 25, 1991 -
JOINT U.S./CANADIAN REVIEW OF DEPRENYL
In October, DAHI will begin the equivalent of clinical trials in the United States for the use of deprenyl to prevent age- related dysfunctions in dogsBioWorld Today | Wednesday, September 25, 1991 -
ENROLLMENT BEGINS FOR AIDS TRIALS
on Tuesday said it has begun enrolling patients in Phase II clinical trials of its anti-AIDS drug, GLQ223BioWorld Today | Wednesday, September 25, 1991 -
PREMIUM FOR GI IS NO BLOCKBUSTER
For the dollars you put in, you're assuming you'll get a greater return and you yourself don't need to manage clinical trials." "AHP's $666 million could have bought a lot of R&D and licensing agreements," said MillerBioWorld Today | Monday, September 23, 1991 -
CEL-SCI TO GET $5 MILLION IN FINANCING
If the offering is successful, the proceeds will be used to pay for clinical trials of HGP-30, a core protein AIDS vaccine being developed in collaboration with Alpha 1 Biomedicals IncBioWorld Today | Friday, September 20, 1991 -
D. BLECH TO INVEST $7 MILLION IN NEORX
The Seattle-based company has three rhenium-labelled antibodies in Phase I clinical trials to treat ovarian cancer, small cell lung cancer, and for intravenous administration for any tumor to which the antibody binds -- primarily colon, lung and breast cancersBioWorld Today | Thursday, September 19, 1991 -
FDA APPROVES MARKETING OF CHIRON LENSES
The company is also conducting clinical trials of EGF in healing corneal wounds and as a component of viscoelastics used in intraocular surgeryBioWorld Today | Thursday, September 19, 1991
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9737)
- x BioWorld International (1950)
- x BioWorld Insight (1198)
- x Bio Perspectives (295)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.